Towards Pharma 4.0 in clinical trials: a future-orientated perspective

Hariry, RE, Vatankhah Barenji, R ORCID: https://orcid.org/0000-0003-2933-0954 and Paradkar, A, 2022. Towards Pharma 4.0 in clinical trials: a future-orientated perspective. Drug Discovery Today, 27 (1), pp. 315-325. ISSN 1359-6446

Preview

Text 1536370_Barenji.pdf - Post-print Download (631kB) | Preview

Abstract

Pharma 4.0, a technology ecosystem in drug development analogous to Industry 4.0 in healthcare, is transforming the traditional approach to drug discovery and development, aligning product quality with less time to market, and creating intelligent stakeholder networks through effective collaborations. The wide range of potential Pharma 4.0 networks have produced several conceptualizations, which have led to a lack of clarity and definition. The main emphasis of this paper is on the clinical trial stage of drug development in the Pharma 4.0 era. It highlights the merged computerized technologies that are currently used in clinical research, and proposes a framework for integrating Pharma 4.0 technologies. The impact of and barriers to employing the proposed framework are discussed, highlighting its potential and some future research applications.

Item Type:	Journal article
Publication Title:	Drug Discovery Today
Creators:	Hariry, R.E., Vatankhah Barenji, R. and Paradkar, A.
Publisher:	Elsevier BV
Date:	January 2022
Volume:	27
Number:	1
ISSN:	1359-6446
Identifiers:	Number Type 10.1016/j.drudis.2021.09.002 DOI 1536370 Other
Divisions:	Schools > School of Science and Technology
Record created by:	Jeremy Silvester
Date Added:	08 Apr 2022 15:14
Last Modified:	16 Sep 2022 03:00
URI:	https://irep.ntu.ac.uk/id/eprint/46080

Actions (login required)

Edit View

Statistics

Views

Downloads